Table 2 Interview of past VL cases on treatment follow-up
Characteristics | Numbers |
|---|---|
Place of VL diagnosis | n = 104 |
Private hospital | 2 (1.9) |
Government hospital | 102 (98.1) |
Drugs used for treatment | n = 104 |
LAmB (5 mg/Kg single dose) + MF (2.5 mg/Kg/per day for 7 days) | 3 (2.8) |
LAmB single dose (10 mg/Kg) | 77 (74.0) |
LAmB multiple doses (5 mg/Kg per day for 3 days) | 15 (14.4) |
Miltefosine (100mg per day for 28 days) | 6 (5.7) |
PMIM (11mg/Kg for 10 days) + LAmB (5 mg/Kg single dose) | 1 (0.9) |
Do not know | 1 (0.9) |
Did not get treatment because of pregnancy | 1 (0.9) |
Doctor call for follow-up | n = 104 |
Yes | 63 (60.6) |
No | 41 (39.4) |
Patient went for follow-up | n = 104 |
Yes | 39 (37.5) |
No | 65 (62.5) |
Monitoring during follow-up by the doctor | n = 39 |
Asked the health status | 35 (89.7) |
Monitored fever | 28 (26.9) |
Measured the spleen size | 25 (64.1) |
Measured the weight | 15 (38.4) |
Monitored the haemoglobin | 22 (56.4) |
Observed the skin lesions | 3 (7.7) |